Avertix Medical announced today that Professor Ian Meredith AM, has agreed to join the Company’s Board of Directors following the closing of the Company’s previously announced business combination with BIOS Acquisition Corporation (BIOS). Professor Meredith recently retired from Boston Scientific (BSX) after serving over six years as its Executive Vice President and Global Chief Medical Officer, where he was responsible for global leadership of medical, clinical science and trial strategy across the organization.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BIOS: